Literature DB >> 22919262

Non-steroidal anti-inflammatory drugs-induced small intestinal injury and probiotic agents.

Mario Guslandi.   

Abstract

Intestinal bacteria play a role in the development of non-steroidal anti-inflammatory drugs (NSAID)-induced small intestinal injury. Agents such as probiotics, able to modify the gut ecology, might theoretically be useful in preventing small intestinal damage induced by NSAIDs. The clinical studies available so far do suggest that some probiotic agents can be effective in this respect.

Entities:  

Keywords:  Intestinal bacteria; Non-steroidal anti-inflammatory drugs; Probiotics; Small intestine

Mesh：

Substances：

Year:  2012        PMID： 22919262      PMCID： PMC3422810          DOI： 10.3748/wjg.v18.i31.4241

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  7 in total

Review 1.  Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.

Authors:  Sung Chul Park; Hoon Jai Chun; Chang Don Kang; Donggeun Sul
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

2.  NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?

Authors:  C Scarpignato
Journal:  Gut       Date:  2008-02       Impact factor: 23.059

3.  Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study.

Authors:  M Montalto; A Gallo; V Curigliano; F D'Onofrio; L Santoro; M Covino; S Dalvai; A Gasbarrini; G Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2010-04-07       Impact factor: 8.171

4.  Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.

Authors:  John L Wallace; Stephanie Syer; Emmanuel Denou; Giada de Palma; Linda Vong; Webb McKnight; Jennifer Jury; Manlio Bolla; Premysl Bercik; Stephen M Collins; Elena Verdu; Ennio Ongini
Journal:  Gastroenterology       Date:  2011-07-13       Impact factor: 22.682

5.  Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans.

Authors:  M Gotteland; S Cruchet; S Verbeke
Journal:  Aliment Pharmacol Ther       Date:  2001-01       Impact factor: 8.171

6.  Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study.

Authors:  Hiroki Endo; Takuma Higurashi; Kunihiro Hosono; Eiji Sakai; Yusuke Sekino; Hiroshi Iida; Yasunari Sakamoto; Tomoko Koide; Hirokazu Takahashi; Masato Yoneda; Chikako Tokoro; Masahiko Inamori; Yasunobu Abe; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2011-05-10       Impact factor: 7.527

7.  Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid.

Authors:  Toshio Watanabe; Hikaru Nishio; Tetsuya Tanigawa; Hirokazu Yamagami; Hirotoshi Okazaki; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Takashi Asahara; Koji Nomoto; Kazuhide Higuchi; Koji Takeuchi; Tetsuo Arakawa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-09       Impact factor: 4.052
  7 in total
  2 in total

Review 1.  Understanding and modulating mammalian-microbial communication for improved human health.

Authors:  Sridhar Mani; Urs A Boelsterli; Matthew R Redinbo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-23       Impact factor: 13.820

Review 2.  Gut Microbiota in NSAID Enteropathy: New Insights From Inside.

Authors:  Xianglu Wang; Qiang Tang; Huiqin Hou; Wanru Zhang; Mengfan Li; Danfeng Chen; Yu Gu; Bangmao Wang; Jingli Hou; Yangping Liu; Hailong Cao
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.